Literature DB >> 10672235

Functional brain imaging in the resting state and during activation in Alzheimer's disease. Implications for disease mechanisms involving oxidative phosphorylation.

S I Rapoport1.   

Abstract

In vivo brain imaging of patients with Alzheimer's disease (AD) using positron emission tomography (PET) demonstrates progressive reductions in resting-state brain glucose metabolism and blood flow in relation to dementia severity, more so in association than primary cortical regions. During cognitive or psychophysical stimulation, blood flow and metabolism in the affected regions can increase to the same extent in mildly demented AD patients as in age-matched controls, suggesting that energy delivery is not rate limiting. Activation declines with dementia severity, and is markedly reduced in severely demented patients. These results suggest that there is an initial "normal" functionally-responsive stage in AD, followed by a late less responsive stage. Studies of biopsied and postmortem brain indicate that the initial stage is accompanied by selective and potentially reversible down-regulation of the brain enzymes, including cytochrome oxidase, which mediate mitochondrial oxidative-phosphorylation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10672235     DOI: 10.1111/j.1749-6632.1999.tb07823.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  10 in total

1.  Altered brain mitochondrial metabolism in healthy aging as assessed by in vivo magnetic resonance spectroscopy.

Authors:  Fawzi Boumezbeur; Graeme F Mason; Robin A de Graaf; Kevin L Behar; Gary W Cline; Gerald I Shulman; Douglas L Rothman; Kitt F Petersen
Journal:  J Cereb Blood Flow Metab       Date:  2009-09-30       Impact factor: 6.200

Review 2.  13C MRS studies of neuroenergetics and neurotransmitter cycling in humans.

Authors:  Douglas L Rothman; Henk M De Feyter; Robin A de Graaf; Graeme F Mason; Kevin L Behar
Journal:  NMR Biomed       Date:  2011-08-31       Impact factor: 4.044

Review 3.  In Vivo 13C Magnetic Resonance Spectroscopy for Assessing Brain Biochemistry in Health and Disease.

Authors:  Rimil Guha Roy; Avantika Samkaria; Pravat K Mandal; Joseph C Maroon; Yashika Arora
Journal:  Neurochem Res       Date:  2022-01-28       Impact factor: 3.996

4.  Reduction in BACE1 decreases body weight, protects against diet-induced obesity and enhances insulin sensitivity in mice.

Authors:  Paul J Meakin; Alex J Harper; D Lee Hamilton; Jennifer Gallagher; Alison D McNeilly; Laura A Burgess; Lobke M Vaanholt; Kirsten A Bannon; Judy Latcham; Ishrut Hussain; John R Speakman; David R Howlett; Michael L J Ashford
Journal:  Biochem J       Date:  2012-01-01       Impact factor: 3.857

Review 5.  Alzheimer's disease and endothelial dysfunction.

Authors:  Giuseppe Bomboi; Lorenzo Castello; Francesco Cosentino; Franco Giubilei; Francesco Orzi; Massimo Volpe
Journal:  Neurol Sci       Date:  2009-10-17       Impact factor: 3.307

6.  Phosphorylation of the translation initiation factor eIF2alpha increases BACE1 levels and promotes amyloidogenesis.

Authors:  Tracy O'Connor; Katherine R Sadleir; Erika Maus; Rodney A Velliquette; Jie Zhao; Sarah L Cole; William A Eimer; Brian Hitt; Leslie A Bembinster; Sven Lammich; Stefan F Lichtenthaler; Sébastien S Hébert; Bart De Strooper; Christian Haass; David A Bennett; Robert Vassar
Journal:  Neuron       Date:  2008-12-26       Impact factor: 17.173

7.  Cognitive stimulation for apathy in probable early-stage Alzheimer's.

Authors:  Linda L Buettner; Suzanne Fitzsimmons; Serdar Atav; Kaycee Sink
Journal:  J Aging Res       Date:  2011-04-28

8.  Efficacy and tolerability of rivastigmine patch therapy in patients with mild-to-moderate Alzheimer's dementia associated with minimal and moderate ischemic white matter hyperintensities: A multicenter prospective open-label clinical trial.

Authors:  Kyung Won Park; Eun-Joo Kim; Hyun Jeong Han; Yong S Shim; Jae C Kwon; Bon D Ku; Kee Hyung Park; Hyon-Ah Yi; Kwang K Kim; Dong Won Yang; Ho-Won Lee; Heeyoung Kang; Oh Dae Kwon; SangYun Kim; Jae-Hyeok Lee; Eun Joo Chung; Sang-Won Park; Mee Young Park; Bora Yoon; Byeong C Kim; Sang Won Seo; Seong Hye Choi
Journal:  PLoS One       Date:  2017-08-07       Impact factor: 3.240

9.  In vivo X-Nuclear MRS Imaging Methods for Quantitative Assessment of Neuroenergetic Biomarkers in Studying Brain Function and Aging.

Authors:  Xiao-Hong Zhu; Wei Chen
Journal:  Front Aging Neurosci       Date:  2018-11-27       Impact factor: 5.750

10.  The Alzheimer's disease beta-secretase enzyme, BACE1.

Authors:  Sarah L Cole; Robert Vassar
Journal:  Mol Neurodegener       Date:  2007-11-15       Impact factor: 14.195

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.